China SXT Pharmaceuticals Total Current Liabilities 2011-2026 | SXTC

Annual Total Current Liabilities China SXT Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
6.01 M	8.9 M	14.5 M	17.1 M	18.6 M	12.3 M	6.32 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
18.6 M	6.01 M	12 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
Avenue Therapeutics ATXI	1.1 M	-	-52.27 %	$ 4.45 M	USA
AbbVie ABBV	43.3 B	$ 213.12	-	$ 377 B	USA
AbCellera Biologics ABCL	64.3 M	$ 3.28	-	$ 980 M	Canada
Acorda Therapeutics ACOR	228 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	22.9 M	-	-	$ 86.2 M	USA
Advaxis ADXS	25 M	-	-9.65 %	$ 45.9 M	USA
AgeX Therapeutics AGE	3.56 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	576 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	3.78 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	39.8 M	-	-	$ 3.67 B	USA
Akouos AKUS	16.8 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	58 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	6.18 M	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	15 M	$ 2.88	-	$ 254 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	15.1 M	-	-	$ 10.1 M	USA
Aptose Biosciences APTO	4.46 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	6.29 M	-	-39.0 %	$ 4.57 M	USA
Amgen AMGN	25.5 B	$ 349.0	-	$ 188 B	USA
Atea Pharmaceuticals AVIR	39.8 M	$ 5.08	-	$ 414 M	USA
AVROBIO AVRO	6.35 M	-	1083.1 %	$ 745 M	USA
Axcella Health AXLA	14.1 M	-	-16.42 %	$ 249 M	USA
Ayala Pharmaceuticals AYLA	7.54 M	-	-	$ 7.46 M	Israel
Axon Enterprise AXON	1.68 B	$ 415.07	-	$ 31.4 B	USA
Atreca BCEL	16.3 M	-	-11.76 %	$ 5.79 M	USA
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
bluebird bio BLUE	200 M	-	-	$ 546 M	USA
Calithera Biosciences CALA	14 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	25.6 M	-	-3.03 %	$ 260 M	USA
Adaptive Biotechnologies Corporation ADPT	89.9 M	$ 12.85	-	$ 1.95 B	USA
Avid Bioservices CDMO	70.6 M	-	-	$ 789 M	USA
ANI Pharmaceuticals ANIP	194 M	$ 73.71	-	$ 1.42 B	USA
Cerevel Therapeutics Holdings CERE	92.2 M	-	-	$ 7.29 B	USA
Clovis Oncology CLVS	125 M	-	-7.23 %	$ 13 M	USA
BioCardia BCDA	2.43 M	$ 1.16	-	$ 7.73 M	USA
BeiGene, Ltd. BGNE	1.83 B	-	0.49 %	$ 251 B	Cayman-islands
Biogen BIIB	3.35 B	$ 187.57	-	$ 27.5 B	USA
Curis CRIS	14.1 M	$ 0.51	-	$ 6.71 M	USA
Autolus Therapeutics plc AUTL	73.4 M	$ 1.27	-	$ 338 M	Britain
Bristol-Myers Squibb Company BMY	23.4 B	$ 59.73	-	$ 121 B	USA
ChemoCentryx CCXI	63 M	-	-	$ 3.74 B	USA